Antiviral Treatment of Coronavirus Disease-2019 Pneumonia

被引：2

作者：

Radcliffe, Christopher ^{[1
]}

Malinis, Maricar

Azar, Marwan M. ^{[1
,2
]}

机构：

[1] Yale Univ, Sch Med, Sect Infect Dis, 333 Cedar St, New Haven, CT 06520 USA

[2] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA

来源：

CLINICS IN CHEST MEDICINE | 2023年 / 44卷 / 02期

关键词：

COVID-19; Tixagevimab; cilgavimab; SARS-CoV-2; Remdesivir; Molnupiravir; Nirmatrelvir; Bebtelovimab; EBOLA-VIRUS; COVID-19; INHIBITOR; EFFICACY; SAFETY;

D O I：

10.1016/j.ccm.2022.11.008

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：279 / 297

页数：19

共 85 条

[1] A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort [J].

Ackley, Tyler W. ;

McManus, Dayna ;

Topal, Jeffrey E. ;

Cicali, Brian ;

Shah, Sunish .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)

[2] A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 [J].

Lundgren J.D. ;

Grund B. ;

Barkauskas C.E. ;

Holland T.L. ;

Gottlieb R.L. ;

Sandkovsky U. ;

Brown S.M. ;

Knowlton K.U. ;

Self W.H. ;

Files D.C. ;

Jain M.K. ;

Benfield T. ;

Bowdish M.E. ;

Leshnower B.G. ;

Baker J.V. ;

Jensen J.-U. ;

Gardner E.M. ;

Ginde A.A. ;

Harris E.S. ;

Johansen I.S. ;

Markowitz N. ;

Matthay M.A. ;

Østergaard L. ;

Chang C.C. ;

Davey V.J. ;

Goodman A. ;

Higgs E.S. ;

Murray D.D. ;

Murray T.A. ;

Paredes R. ;

Parmar M.K.B. ;

Phillips A.N. ;

Reilly C. ;

Sharma S. ;

Dewar R.L. ;

Teitelbaum M. ;

Wentworth D. ;

Cao H. ;

Klekotka P. ;

Babiker A.G. ;

Gelijns A.C. ;

Kan V.L. ;

Polizzotto M.N. ;

Thompson B.T. ;

Lane H.C. ;

Neaton J.D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (10) :905-914

[3]

[Anonymous], 2022, Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID™ for Post-Exposure Prophylactic Use. Pfizer

[4]

[Anonymous], VER NOV COVID 19 DRU

[5]

Arribas Jose R, 2022, NEJM Evid, V1, pEVIDoa2100044, DOI 10.1056/EVIDoa2100044

[6]

Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]

[7] Severe Covid-19 [J].

Berlin, David A. ;

Gulick, Roy M. ;

Martinez, Fernando J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2451-2460

[8] Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients [J].

Bernal, A. Jayk ;

da Silva, M. M. Gomes ;

Musungaie, D. B. ;

Kovalchuk, E. ;

Gonzalez, A. ;

Delos Reyes, V ;

Martin-Quiros, A. ;

Caraco, Y. ;

Williams-Diaz, A. ;

Brown, M. L. ;

Du, J. ;

Pedley, A. ;

Assaid, C. ;

Strizki, J. ;

Grobler, J. A. ;

Shamsuddin, H. H. ;

Tipping, R. ;

Wan, H. ;

Paschke, A. ;

Butterton, J. R. ;

Johnson, M. G. ;

De Anda, C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) :509-520

[9]

Bhuta S, 2022, AM J THER, V29, P298

[10] Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial [J].

Bosaeed, Mohammad ;

Alharbi, Ahmad ;

Mahmoud, Ebrahim ;

Alrehily, Sanaa ;

Bahlaq, Mohannad ;

Gaifer, Zied ;

Alturkistani, Hanan ;

Alhagan, Khaled ;

Alshahrani, Saad ;

Tolbah, Ali ;

Musattat, Abrar ;

Alanazi, Maha ;

Jaha, Raniah ;

Sultana, Khizra ;

Alqahtani, Hajar ;

Al Aamer, Kholoud ;

Jaser, Saud ;

Alsaedy, Abdulrahman ;

Ahmad, Ayoub ;

Abalkhail, Mohammed ;

AlJohani, Sameera ;

Al Jeraisy, Majed ;

Almaziad, Sultan ;

Albaalharith, Nahlah ;

Alabdulkareem, Khaled ;

Alshowair, Abdulmajeed ;

Alharbi, Naif Khalaf ;

Alrabiah, Fahad ;

Alshamrani, Majid ;

Aldibasi, Omar ;

Alaskar, Ahmed .

CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) :602-608

← 1 2 3 4 5 6 7 8 9 →